Further statistical issues in project prioritization in the pharmaceutical industry

Drug Information Journal

Volumn 32, Issue 1, 1998, Pages 253-259

  Senn, Stephen ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Pharmaceutical industry; Portfolio management; Statistical issues

Indexed keywords

DRUG INDUSTRY; DRUG RESEARCH; PHARMACOECONOMICS; PLANNING; PRIORITY JOURNAL; REVIEW; RISK MANAGEMENT; STATISTICS;

EID: 0031941667     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286159803200133     Document Type: Review

References (10)

1. Senn SJ. Some statistical issues in project prioritization in the pharmaceutical industry. Stat Med. 1996;15:2689-2702.
2. Gittins JC. Quantitative methods in the planning of pharmaceutical research. Drug Inf J. 1996;30:479-487.
3. Pearson AW. The use of ranking formulae in R&D projects. R&D Manage. 1972;2:69-73.
4. Dixit AK, Pindyck RS. Investment Under Uncertainty. Princeton: Princeton University Press; 1994.
5. Owen D. Selecting projects to obtain a balanced research portfolio. In: Howard RA, Matheson JE, eds. The Principles and Applications of Decision Analysis. Menlo Park: Strategic Decisions Group; 1989.
6. Markowitz H. Portfolio selection. J Finance. 1952;7:77-91.
7. O'Hagan A. Probability Methods and Measurement. London and New York: Chapman and Hall; 1987.
8. Hill T. Calculating the cost of clinical research. Scrip Magazine. 1994;March:28-30.
9. Gittins JC. A planning procedure for new-product chemical research. R&D Manage. 1994;24:219-227.
10. Hull JC. Options, Futures and Other Derivative Securities. Eaglewood Cliffs, NJ: Prentice-Hall. 1989.